Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...

The Fed is facing one of its most daunting situations in years. I’m shifting capital before this risk becomes obvious. Click ...

Artificial intelligence, electromobility, and new safety requirements are fueling demand for specialized high-performance batteries. These key components are driving not only autonomous vehicles, but ...

HEICO's actual results may differ materially from those expressed in or implied by those forward-looking statements. Factors ...

Joining me are Rick Cardenas, Darden's President and CEO; and Raj Vennam, CFO. Several of our brands set sales records during ...

Novo Nordisk’s weight-loss challenge in five charts ...

Plus, 21 Savage's latest project arrives, while a record-tying six of the top 10 are holiday albums. By Keith Caulfield Taylor Swift’s The Life of a Showgirl hits double-digit weeks at No. 1 on the ...

Although it sometimes feels like streaming is the only arena that counts, a recent report from Morgan Stanley media analysts ...

LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk ‌secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost to rival Eli Lilly. Booming ...

We’ll show you how to keep your mind sharp and resilient for years to come. Signing up with a partner may bring even bigger benefits. By Dana G. Smith Your brain is ...

Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...